NYMOX PHARMACEUTICAL CORP Quarterly General And Administrative Expense in USD from Q1 2021 to Q3 2023

Taxonomy & unit
ifrs-full: USD
Summary
Nymox Pharmaceutical Corp quarterly General And Administrative Expense history and growth rate from Q1 2021 to Q3 2023.
  • Nymox Pharmaceutical Corp General And Administrative Expense for the quarter ending September 30, 2023 was $353K, a 39.8% decline year-over-year.
General And Administrative Expense, Quarterly (USD)
General And Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $353K -$233K -39.8% Jul 1, 2023 Sep 30, 2023 6-K 2023-11-15
Q2 2023 $505K -$458K -47.6% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-14
Q1 2023 $665K -$75K -10.1% Jan 1, 2023 Mar 31, 2023 6-K 2023-05-12
Q3 2022 $586K -$869K -59.7% Jul 1, 2022 Sep 30, 2022 6-K 2023-11-15
Q2 2022 $963K -$949K -49.6% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-14
Q1 2022 $740K -$264K -26.3% Jan 1, 2022 Mar 31, 2022 6-K 2023-05-12
Q3 2021 $1.46M Jul 1, 2021 Sep 30, 2021 6-K/A 2022-11-16
Q2 2021 $1.91M Apr 1, 2021 Jun 30, 2021 6-K 2022-08-15
Q1 2021 $1M Jan 1, 2021 Mar 31, 2021 6-K 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.